A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.

by Michael C Keefer, Jill Gilmour, Peter Hayes, Dilbinder Gill, Jakub Kopycinski, Hannah Cheeseman, Michelle Cashin-Cox, Marloes Naarding, Lorna Clark, Natalia Fernandez, Catherine A Bunce, Christine M Hay, Sabrina Welsh, Wendy Komaroff, Lottie Hachaambwa, Tony Tarragona-Fiol, Eddy Sayeed, Devika Zachariah, James Ackland, Kelley Loughran, Burc Barin, Emmanuel Cormier, Josephine H Cox, Patricia Fast, Jean-Louis Excler
Published 2012-01-01

Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa.

by Walter Jaoko, Etienne Karita, Kayitesi Kayitenkore, Gloria Omosa-Manyonyi, Susan Allen, Soe Than, Elizabeth M Adams, Barney S Graham, Richard A Koup, Robert T Bailer, Carol Smith, Len Dally, Bashir Farah, Omu Anzala, Claude M Muvunyi, Jean Bizimana, Tony Tarragona-Fiol, Philip J Bergin, Peter Hayes, Martin Ho, Kelley Loughran, Wendy Komaroff, Gwynneth Stevens, Helen Thomson, Mark J Boaz, Josephine H Cox, Claudia Schmidt, Jill Gilmour, Gary J Nabel, Patricia Fast, Job Bwayo
Published 2010-09-01